Lane Andrew A, Ley Timothy J
Division of Oncology, Department of Medicine, Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO 63110, USA.
Cell. 2003 Oct 31;115(3):305-18. doi: 10.1016/s0092-8674(03)00852-3.
The fusion protein PML-RARalpha, generated by the t(15;17)(q22;q11.2) translocation associated with acute promyelocytic leukemia (APL), initiates APL when expressed in the early myeloid compartment of transgenic mice. PML-RARalpha is cleaved in several positions by a neutral serine protease in a human myeloid cell line; purification revealed that the protease is neutrophil elastase (NE). Immunofluorescence localization studies suggested that the cleavage of PML-RARalpha must occur within the cell, and perhaps, within the nucleus. The functional importance of NE for APL development was assessed in NE deficient mice. Greater than 90% of bone marrow PML-RARalpha cleaving activity was lost in the absence of NE, and NE (but not Cathepsin G) deficient animals were protected from APL development. Primary mouse and human APL cells also contain NE-dependent PML-RARalpha cleaving activity. Since NE is maximally produced in promyelocytes, this protease may play a role in APL pathogenesis by facilitating the leukemogenic potential of PML-RARalpha.
由与急性早幼粒细胞白血病(APL)相关的t(15;17)(q22;q11.2)易位产生的融合蛋白PML-RARα,在转基因小鼠的早期髓系区室中表达时会引发APL。在人髓系细胞系中,PML-RARα在多个位置被一种中性丝氨酸蛋白酶切割;纯化显示该蛋白酶是中性粒细胞弹性蛋白酶(NE)。免疫荧光定位研究表明,PML-RARα的切割必定发生在细胞内,或许还发生在细胞核内。在NE缺陷小鼠中评估了NE对APL发展的功能重要性。在没有NE的情况下,超过90%的骨髓PML-RARα切割活性丧失,并且NE(而非组织蛋白酶G)缺陷的动物可免受APL发展的影响。原代小鼠和人APL细胞也含有NE依赖性的PML-RARα切割活性。由于NE在早幼粒细胞中产生最多,这种蛋白酶可能通过促进PML-RARα的致白血病潜能在APL发病机制中发挥作用。